There is no completed human efficacy trial, which is why all dosing here is research-use-only
Rare cases of allergic contact dermatitis have been described with prolonged copper exposure, so persistent or worsening inflammation should prompt discontinuation and medical evaluation
The second is dose and route translation : even where an effect is real in a mouse, the human-equivalent dose is not a simple body-weight scaling, and as the route section above stressed there is no human bioavailability figure to anchor an oral-versus-injected comparison
age-related plasma decline (roughly 200 ng/mL at age 20 to about 80 ng/mL by 60): Pickart L, Margolina A
The interest in 5-Amino-1MQ rests on a small number of preclinical studies, and it is important to name what kind of evidence each is
Users administer Wegovy orally for weight management